InVivoMAb anti-mouse OX40L (CD134L)
BE0033-1
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse OX40L (CD134L)
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDRM134L
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2b
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Welten SP, Redeker A, Franken KL, et al. The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. Elife. 2015,4. doi: 10.7554/eLife.07486Read this paper
- Baeyens A, Saadoun D, Billiard F, et al. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context. J Immunol. 2015,194(3):999-1010. doi: 10.4049/jimmunol.1400504Read this paper
- Xin L, Jiang TT, Chaturvedi V, et al. Commensal microbes drive intestinal inflammation by IL-17-producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2. Proc Natl Acad Sci U S A. 2014,111(29):10672-7. doi: 10.1073/pnas.1402336111Read this paper
- Mahmud SA, Manlove LS, Schmitz HM, et al. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat Immunol. 2014,15(5):473-81. doi: 10.1038/ni.2849Read this paper
- Leyva-Castillo JM, Hener P, Michea P, et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun. 2013,4:2847. doi: 10.1038/ncomms3847Read this paper
- Hong J, Yeom HJ, Lee E, et al. Islet allograft rejection in sensitized mice is refractory to control by combination therapy of immune-modulating agents. Transpl Immunol. 2013,28(2-3):86-92. doi: 10.1016/j.trim.2013.01.005Read this paper
- Sanchez PJ, Kedl RM. An alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling. Vaccine. 2012,30(6):1154-61. doi: 10.1016/j.vaccine.2011.12.017Read this paper
- Kurche JS, Burchill MA, Sanchez PJ, et al. Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses. J Immunol. 2010,185(4):2106-15. doi: 10.4049/jimmunol.1000172Read this paper
- Vu MD, Clarkson MR, Yagita H, et al. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol. 2006,176(3):1394-401.Read this paper
